Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
3(14%)
Results Posted
31%(4 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
9
43%
Ph phase_1
5
24%
Ph phase_4
1
5%
Ph phase_2
4
19%
Ph phase_3
2
10%

Phase Distribution

5

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
5(23.8%)
Phase 2Efficacy & side effects
4(19.0%)
Phase 3Large-scale testing
2(9.5%)
Phase 4Post-market surveillance
1(4.8%)
N/ANon-phased studies
9(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(13)
Terminated(1)
Other(3)

Detailed Status

Completed13
unknown3
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (23.8%)
Phase 24 (19.0%)
Phase 32 (9.5%)
Phase 41 (4.8%)
N/A9 (42.9%)

Trials by Status

recruiting210%
active_not_recruiting15%
completed1362%
not_yet_recruiting15%
terminated15%
unknown314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07304440Phase 1

Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study

Active Not Recruiting
NCT07448415Phase 2

Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma

Not Yet Recruiting
NCT06922669Not Applicable

Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia

Recruiting
NCT05954052Phase 4

A Study of Glutathione in Children With Autism Spectrum Disorder

Terminated
NCT06896422Phase 1

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

Recruiting
NCT02251041Phase 2

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)

Completed
NCT01550432Not Applicable

Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation

Completed
NCT04672447Not Applicable

Effect of 4 Weeks of Citrulline and Glutathione Supplementation on Arterial Function

Completed
NCT02584283Phase 3

Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation

Completed
NCT02848417Phase 1

Glutathione vs. Curcumin Clinical Trial

Unknown
NCT04105504Phase 1

Oral Glutathione As A Skin Whitening Agent

Completed
NCT02948673Not Applicable

The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise

Completed
NCT02311907Phase 3

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Completed
NCT01402570Not Applicable

Glutathione and Health With Post-Polio Syndrome

Completed
NCT00889538Not Applicable

Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

Completed
NCT02321579Not Applicable

Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities

Unknown
NCT01142024Not Applicable

Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced Nephropathy

Completed
NCT01177319Phase 2

Glutathione (GSH) In The Treatment of Parkinson's Disease

Completed
NCT01016080Phase 1

Role of Oral Glutathione in Skin Whitening

Completed
NCT00323583Phase 2

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
21